Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Role of the PPAR-α agonist fenofibrate in severe pediatric burn
Itoro E. Elijah
, Elisabet Børsheim
, Dirk M. Maybauer
,
Celeste C. Finnerty
, David N. Herndon
, Marc O. Maybauer
Surgery
Research output
:
Contribution to journal
›
Review article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Role of the PPAR-α agonist fenofibrate in severe pediatric burn'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pediatric Burns
100%
Fenofibrate
100%
PPAR Agonists
100%
Hyperglycemia
50%
Insulin Resistance
50%
Wound Healing
25%
Apoptosis
25%
Diabetes
25%
Insulin Sensitivity
25%
Mechanism of Action
25%
Oxidative Stress
25%
Insulin
25%
Liver
25%
Poor Outcome
25%
Catecholamines
25%
Mitochondrial Function
25%
Skeletal muscle
25%
Severely Burned Patients
25%
Fatty Acid Oxidation
25%
Insulin Signaling
25%
Peroxisome Proliferator-activated Receptor
25%
Renal Cell
25%
Cardiac Cells
25%
Anti-inflammatory Properties
25%
Dyslipidemia
25%
Glucose-insulin System
25%
Common Complications
25%
Systemic Regulation
25%
Hypoglycemic Episodes
25%
Glucose Oxidation
25%
Skeletal muscle Cells
25%
Oxidation Sensitivity
25%
Hepatic Glucose Production
25%
Alpha Agonist
25%
Inflammatory Properties
25%
Glycogenolysis
25%
Lipoprotein Metabolism
25%
Fatty Acid Transport
25%
Medicine and Dentistry
Pediatric Burn
100%
Peroxisome Proliferator Activated Receptor Agonist
100%
Fenofibrate
100%
Hyperglycemia
50%
Insulin Resistance
50%
Skeletal Muscle
50%
Wound Healing
25%
Insulin Sensitivity
25%
Diabetes
25%
Oxidative Stress
25%
Programmed Cell Death
25%
Receptor
25%
Catecholamine
25%
Antidiabetic Agent
25%
Dyslipidemia
25%
Insulin Signaling
25%
Anti-Inflammatory Drug
25%
Fatty Acid Oxidation
25%
Gluconeogenesis
25%
Glucose Oxidation
25%
Cardiac Muscle
25%
Lipoprotein Metabolism
25%
Fatty Acid Transport
25%
Glycogenolysis
25%
Peroxisome Proliferator Activated Receptor Alpha Agonist
25%
Pharmacology, Toxicology and Pharmaceutical Science
Burn
100%
PPAR Agonist
100%
Fenofibrate
100%
Fatty Acid
50%
Hyperglycemia
50%
Insulin Resistance
50%
Wound Healing
25%
Lipoprotein
25%
Receptor
25%
Catecholamine
25%
Antidiabetic Agent
25%
Anti-Inflammatory Drug
25%
Dyslipidemia
25%
Peroxisome Proliferator Activated Receptor Alpha Agonist
25%